Paper Details

Paper Title

Chemoimmunotherapy after progression on single-agent pembrolizumab for metastatic urothelial carcinoma: a case series.

Paper Journal Title

Anticancer Drugs

Paper Citation Count

Paper Publication Year

2021

Bio Mention

Mesh Descriptor

Column Actions